ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis

BIT:1ABBV • US00287Y1091

185.2 EUR
+0.2 (+0.11%)
Last: Jan 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall 1ABBV gets a fundamental rating of 4 out of 10. We evaluated 1ABBV against 75 industry peers in the Biotechnology industry. While 1ABBV is still in line with the averages on profitability rating, there are concerns on its financial health. 1ABBV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • 1ABBV had positive earnings in the past year.
  • 1ABBV had a positive operating cash flow in the past year.
  • 1ABBV had positive earnings in 4 of the past 5 years.
  • Of the past 5 years 1ABBV 4 years had a positive operating cash flow.
1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 1ABBV has a Return On Assets of 1.75%. This is in the better half of the industry: 1ABBV outperforms 74.12% of its industry peers.
  • 1ABBV has a better Return On Invested Capital (15.64%) than 89.41% of its industry peers.
  • 1ABBV had an Average Return On Invested Capital over the past 3 years of 13.67%. This is in line with the industry average of 12.19%.
  • The last Return On Invested Capital (15.64%) for 1ABBV is above the 3 year average (13.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROIC 15.64%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1ABBV.MI Yearly ROA, ROE, ROIC1ABBV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.94%, 1ABBV is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1ABBV has declined.
  • With an excellent Operating Margin value of 33.05%, 1ABBV belongs to the best of the industry, outperforming 87.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ABBV has declined.
  • With a Gross Margin value of 71.16%, 1ABBV perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1ABBV has declined.
Industry RankSector Rank
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
1ABBV.MI Yearly Profit, Operating, Gross Margins1ABBV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1ABBV is creating value.
  • There is no outstanding debt for 1ABBV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ABBV.MI Yearly Shares Outstanding1ABBV.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
1ABBV.MI Yearly Total Debt VS Total Assets1ABBV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • 1ABBV has an Altman-Z score of 2.38. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.38, 1ABBV is doing good in the industry, outperforming 71.76% of the companies in the same industry.
  • 1ABBV has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as 1ABBV would need 3.49 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1ABBV (3.49) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Altman-Z 2.38
ROIC/WACC1.87
WACC8.37%
1ABBV.MI Yearly LT Debt VS Equity VS FCF1ABBV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.72 indicates that 1ABBV may have some problems paying its short term obligations.
  • 1ABBV's Current ratio of 0.72 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 78.82% of its industry peers.
  • 1ABBV has a Quick Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV has a worse Quick ratio (0.60) than 78.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.6
1ABBV.MI Yearly Current Assets VS Current Liabilites1ABBV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for 1ABBV have decreased by -1.19% in the last year.
  • The Earnings Per Share has been decreasing by -0.99% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.04%

3.2 Future

  • 1ABBV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.29% yearly.
  • The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.29%
Revenue Next Year9.84%
Revenue Next 2Y8.84%
Revenue Next 3Y7.94%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
1ABBV.MI Yearly Revenue VS Estimates1ABBV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
1ABBV.MI Yearly EPS VS Estimates1ABBV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.84, 1ABBV is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 81.18% of the companies listed in the same industry.
  • 1ABBV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 15.04, which indicates a correct valuation of 1ABBV.
  • 1ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 91.76% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, 1ABBV is valued a bit cheaper.
Industry RankSector Rank
PE 21.84
Fwd PE 15.04
1ABBV.MI Price Earnings VS Forward Price Earnings1ABBV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 78.82% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1ABBV is valued cheaper than 90.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.61
EV/EBITDA 15.92
1ABBV.MI Per share data1ABBV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1ABBV's earnings are expected to grow with 21.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3Y21.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • 1ABBV has a Yearly Dividend Yield of 3.16%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.62, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 97.65% of the companies listed in the same industry.
  • 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

  • On average, the dividend of 1ABBV grows each year by 7.72%, which is quite nice.
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1ABBV pays out 489.69% of its income as dividend. This is not a sustainable payout ratio.
  • 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP489.69%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
1ABBV.MI Yearly Income VS Free CF VS Dividend1ABBV.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1ABBV.MI Dividend Payout.1ABBV.MI Dividend Payout, showing the Payout Ratio.1ABBV.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBVIE INC

BIT:1ABBV (1/26/2026, 7:00:00 PM)

185.2

+0.2 (+0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-23
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap327.32B
Revenue(TTM)N/A
Net Income(TTM)2.35B
Analysts78.38
Price Target214.66 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly Dividend5.29
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)0.56%
PT rev (3m)8.51%
EPS NQ rev (1m)-20.87%
EPS NQ rev (3m)-20.2%
EPS NY rev (1m)-6.62%
EPS NY rev (3m)-5.66%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 21.84
Fwd PE 15.04
P/S 6.47
P/FCF 19.61
P/OCF 18.51
P/B N/A
P/tB N/A
EV/EBITDA 15.92
EPS(TTM)8.48
EY4.58%
EPS(NY)12.31
Fwd EY6.65%
FCF(TTM)9.44
FCFY5.1%
OCF(TTM)10.01
OCFY5.4%
SpS28.61
BVpS-1.27
TBVpS-44.42
PEG (NY)0.48
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.75%
ROE N/A
ROCE 20.86%
ROIC 15.64%
ROICexc 16.59%
ROICexgc 572.43%
OM 33.05%
PM (TTM) 3.94%
GM 71.16%
FCFM 33%
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.49
Debt/EBITDA 2.39
Cap/Depr 14.25%
Cap/Sales 1.97%
Interest Coverage 250
Cash Conversion 74.59%
Profit Quality 838.33%
Current Ratio 0.72
Quick Ratio 0.6
Altman-Z 2.38
F-Score7
WACC8.37%
ROIC/WACC1.87
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.04%
Revenue Next Year9.84%
Revenue Next 2Y8.84%
Revenue Next 3Y7.94%
Revenue Next 5Y6.02%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year-0.19%
EBIT Next 3Y15.91%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%

ABBVIE INC / 1ABBV.MI FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.


What is the valuation status of ABBVIE INC (1ABBV.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.


What is the profitability of 1ABBV stock?

ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.


What is the valuation of ABBVIE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 21.84 and the Price/Book (PB) ratio is -146.12.


Can you provide the dividend sustainability for 1ABBV stock?

The dividend rating of ABBVIE INC (1ABBV.MI) is 6 / 10 and the dividend payout ratio is 489.69%.